Home - Products - GPCR/G Protein - Adrenergic Receptor - Butofilolol

Butofilolol

CAS No. 58930-32-8

Butofilolol( —— )

Catalog No. M35470 CAS No. 58930-32-8

Butofilolol is a novel beta-blocker with antihypertensive activity and can be used to study hypertension.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	686	In Stock
10MG	938	In Stock
25MG	1444	In Stock
50MG	1841	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Butofilolol
Note

Research use only, not for human use.
Brief Description

Butofilolol is a novel beta-blocker with antihypertensive activity and can be used to study hypertension.
Description

Butofilolol is a potent β-blocking agent used in the research of hypertension.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Adrenergic Receptor
Recptor

Adrenergic Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

58930-32-8
Formula Weight

311.392
Molecular Formula

C17H26FNO3
Purity

>98% (HPLC)
Solubility

——
SMILES

CCCC(=O)c1cc(F)ccc1OCC(O)CNC(C)(C)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Toussain P, et al. Long-term hypotensive treatment by butofilolol. Ann Cardiol Angeiol (Paris). 1983 Jun;32(4):277-83.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

(3aR,9aR)-Fluparoxan

(3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.
Pipoxazole

Pipoxazole (COR-32-24) is an adrenergic receptor agonist that can be used to study depression.
Olodaterol

A potent, selective long-acting β2 adrenoceptor agonist with EC50 of 1.4 nM for hβ2; shows >250 fold selectivity over hβ1; exerts a bronchodilatory efficacy over 24 h in dogs and guinea pigs in the absence of systemic pharmacodynamic effects.COPDPhase 3 Clinical

Sign In Join Free